ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 54 filers reported holding ENTRADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,425,784 | $64,173,868 | 26.74% |
| 5AM Venture Management, LLC | 4,408,379 | $63,921,496 | 16.35% |
| 72 Investment Holdings, LLC | 509,023 | $7,380,833 | 3.50% |
| StepStone Group LP | 761,277 | $11,038,517 | 2.05% |
| TCG Crossover Management, LLC | 584,955 | $8,481,848 | 1.65% |
| Redmile Group, LLC | 1,831,608 | $26,558,316 | 1.15% |
| Nan Fung Group Holdings Ltd | 73,582 | $1,066,939 | 0.73% |
| Baker Brothers Advisors | 4,865,819 | $70,554,376 | 0.38% |
| CHI Advisors LLC | 56,374 | $817,423 | 0.22% |
| MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,522,500 | 0.03% |
| Laurion Capital Management LP | 199,066 | $2,886,457 | 0.02% |
| Y-Intercept (Hong Kong) Ltd | 10,188 | $147,726 | 0.02% |
| 683 Capital Management, LLC | 10,355 | $150,148 | 0.01% |
| HRT FINANCIAL LP | 38,395 | $556 | 0.01% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,983,863 | $43,267 | 0.01% |
| NATIXIS | 31,186 | $444,401 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,014,453 | $14,709,569 | 0.00% |
| LMR Partners LLP | 13,023 | $188,834 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 197,253 | $2,860 | 0.00% |
| Point72 Middle East FZE | 3,441 | $49,895 | 0.00% |
This page lists ENTRADA THERAPEUTICS INC's shareholders in Q1 2023. To view ENTRADA THERAPEUTICS INC's shareholder history, click here.